Profitelligence Profitelligence · Filing Ledger Open MRK research →

Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-08-05

Williams David Michael Files Merck & Co. (MRK) Form 4 - August 05, 2026

Williams David Michael traded 158.5K MRK shares worth $10.7M in this Form 4 filing, reported to the SEC on 2026-08-05.

Issuer
Merck & Co., Inc. MRK · NYSE
Filed
Period
2026-08-05
Accession
0000310158-26-000214

Transactions (9)

Insider Date Type Shares Price Value Own
Williams David Michael 2026-08-05 Sell 4.6K $0.00 $0.00 Direct
Williams David Michael 2026-08-05 Sell 13.5K $0.00 $0.00 Direct
Williams David Michael 2026-08-05 Sell 34.7K $128.77 $4.5M Direct
Williams David Michael 2026-08-05 Sell 34.7K $0.00 $0.00 Direct
Williams David Michael 2026-08-05 Buy 34.7K $73.73 $2.6M Direct
Williams David Michael 2026-08-05 Sell 4.6K $128.77 $592.3K Direct
Williams David Michael 2026-08-05 Sell 13.5K $128.77 $1.7M Direct
Williams David Michael 2026-08-05 Buy 13.5K $75.36 $1.0M Direct
Williams David Michael 2026-08-05 Buy 4.6K $77.62 $357.1K Direct
Net change−52.8K−$2.9M

About Merck & Co., Inc.

Merck & Co., Inc. is a prominent player in the global pharmaceutical industry. It is primarily focused on the research, development, production, and marketing of drugs and vaccines. Known for its strong emphasis on innovative health solutions, Merck develops treatments and vaccines for a variety of diseases affecting humans and animals. Key areas include oncology, infectious diseases, diabetes, and vaccines, reflecting its commitment to addressing critical health challenges worldwide. The company operates in several strategic regions, exporting its advanced therapies to meet healthcare needs across different markets. With a robust pipeline of new products and significant investment in research and development, Merck plays a vital role in advancing medical breakthroughs and enhancing patient care. Beyond pharmaceuticals, Merck is involved in animal health, providing veterinary vaccines and services, contributing to agricultural productivity and food security. The company's ongoing efforts in groundbreaking research and public health initiatives underscore its importance in the healthcare sector.

Exchange NYSE Industry Drug Manufacturers - General Company website ↗

Track MRK insider activity

Get alerted when Merck & Co., Inc. executives buy or sell their shares.

Set up free alerts